ProkidneyPROK
13F holders, Q2 2025 (June 30)6holders
$0.59avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Prokidney Corp. (PROK) in their 13F filings. The largest holders were Marshall Wace, LLP ($274K), Catalyst Funds Management Pty Ltd ($36K) and EverSource Wealth Advisors, LLC ($602).
- Company
- Prokidney Corp.
- CUSIP
- 74291D104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $311K |
| Exits | 0 | $0 |
Ownership 6 holders
| Marshall Wace, LLP | 0.00% | New | 464,812 | $274K |
| Catalyst Funds Management Pty Ltd | 0.01% | New | 61,100 | $36K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 1,017 | $602 |
| Essential Partners LLC | 0.00% | — | 528 | $313 |
| Fortitude Family Office, LLC | 0.00% | New | 490 | $290 |
| SBI Securities Co., Ltd. | 0.00% | New | 201 | $119 |
"% of holder's portfolio" is PROK's weight in each manager's 13F, not the share of Prokidney Corp. the manager owns.